(Q42210454)

English

Coxsackievirus A 16 infection does not interfere with the specific immune response induced by an enterovirus 71 inactivated vaccine in rhesus monkeys

scientific article published on 21 June 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Coxsackievirus A 16 infection does not interfere with the specific immune response induced by an enterovirus 71 inactivated vaccine in rhesus monkeys (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

0 references

author name string

Jingjing Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Sudong Qi

2

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Xiaolong Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Ying Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Longding Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Yanchun Che

6

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Zhanlong He

7

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Yuan Zhao

8

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Shuaiyao Lu

9

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Wenhai Yu

10

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Qihan Li

11

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

language of work or name

0 references

publication date

21 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

4436-4442

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

An overview of the evolution of enterovirus 71 and its clinical and public health significance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Fatal enterovirus 71 encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Selection and characterization of vaccine strain for Enterovirus 71 vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Adaptation of enterovirus 71 to adult interferon deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Pathogenesis study of enterovirus 71 infection in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

A comparative study of the characteristics of two Coxsackie A virus type 16 strains (genotype B).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Analysis of the Th1/Th2 reaction in the immune response induced by EV71 inactivated vaccine in neonatal rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Study of the integrated immune response induced by an inactivated EV71 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Excessive proinflammatory cytokine and chemokine responses of human monocyte-derived macrophages to enterovirus 71 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

An inactivated enterovirus 71 vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

A neonatal mouse model of coxsackievirus A16 for vaccine evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.062

7 January 2021

Identifiers

10.1016/J.VACCINE.2014.06.062

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42210454&oldid=1936004135"